Literature DB >> 29305058

Altered gastrointestinal motility in an animal model of Lesch-Nyhan disease.

Maria G Zizzo1, Monica Frinchi2, Domenico Nuzzo3, Hyder A Jinnah4, Giuseppa Mudò2, Daniele F Condorelli5, Francesco Caciagli6, Renata Ciccarelli6, Patrizia Di Iorio6, Flavia Mulè7, Natale Belluardo8, Rosa Serio7.   

Abstract

Mutations in the HGPRT1 gene, which encodes hypoxanthine-guanine phosphoribosyltransferase (HGprt), housekeeping enzyme responsible for recycling purines, lead to Lesch-Nyhan disease (LND). Clinical expression of LND indicates that HGprt deficiency has adverse effects on gastrointestinal motility. Therefore, we aimed to evaluate intestinal motility in HGprt knockout mice (HGprt¯). Spontaneous and neurally evoked mechanical activity was recorded in vitro as changes in isometric tension in circular muscle strips of distal colon. HGprt¯ tissues showed a lower in amplitude spontaneous activity and atropine-sensitivity neural contraction compared to control mice. The responses to carbachol and to high KCl were reduced, demonstrating a widespread impairment of contractility. L-NAME was not able in the HGprt¯ tissues to restore the large amplitude contractile activity typical of control. In HGprt¯ colon, a reduced expression of dopaminergic D1 receptor was observed together with the loss of its tonic inhibitory activity present in control-mice. The analysis of inflammatory and oxidative stress in colonic tissue of HGprt¯ mice revealed a significant increase of lipid peroxidation associated with over production of oxygen free radicals. In conclusion, HGprt deficiency in mice is associated with a decrease in colon contractility, not dependent upon reduction of acetylcholine release from the myenteric plexus or hyperactivity of inhibitory signalling. By contrast the increased levels of oxidative stress could partially explain the reduced colon motility in HGprt¯ mice. Colonic dysmotility observed in HGprt¯ mice may mimic the gastrointestinal dysfunctions symptoms of human syndrome, providing a useful animal model to elucidate the pathophysiology of this problem in the LND.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Colon; Cytokines; Dopamine; Gastrointestinal motility; HGprt deficient mice; HGprt enzyme; Lesch-Nyhan; Oxidative stress

Mesh:

Substances:

Year:  2017        PMID: 29305058      PMCID: PMC5904834          DOI: 10.1016/j.autneu.2017.12.007

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  29 in total

1.  Oxidative stress and dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease.

Authors:  Jasper E Visser; Doug W Smith; Sheryl S Moy; George R Breese; Theodore Friedmann; Jeffrey D Rothstein; H A Jinnah
Journal:  Brain Res Dev Brain Res       Date:  2002-02-28

2.  Postnatal development of the dopaminergic signaling involved in the modulation of intestinal motility in mice.

Authors:  Maria Grazia Zizzo; Giacomo Cavallaro; Michelangelo Auteri; Gaetano Caldara; Ilaria Amodeo; Mariangela Mastropaolo; Domenico Nuzzo; Marta Di Carlo; Monica Fumagalli; Fabio Mosca; Flavia Mule; Rosa Serio
Journal:  Pediatr Res       Date:  2016-04-18       Impact factor: 3.756

Review 3.  The spectrum of inherited mutations causing HPRT deficiency: 75 new cases and a review of 196 previously reported cases.

Authors:  H A Jinnah; L De Gregorio; J C Harris; W L Nyhan; J P O'Neill
Journal:  Mutat Res       Date:  2000-10       Impact factor: 2.433

4.  Can guanine-based purines be considered modulators of intestinal motility in rodents?

Authors:  Maria Grazia Zizzo; Flavia Mulè; Mariangela Mastropaolo; Daniele F Condorelli; Natale Belluardo; Rosa Serio
Journal:  Eur J Pharmacol       Date:  2010-10-15       Impact factor: 4.432

5.  Adenosine transport in HPRT deficient lymphocytes from Lesch-Nyhan disease patients.

Authors:  R J Torres; I DeAntonio; C Prior; J G Puig
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2004-10       Impact factor: 1.381

6.  Recovery of damaged skeletal muscle in mdx mice through low-intensity endurance exercise.

Authors:  M Frinchi; F Macaluso; A Licciardi; V Perciavalle; M Coco; N Belluardo; G Morici; G Mudò
Journal:  Int J Sports Med       Date:  2013-07-18       Impact factor: 3.118

Review 7.  Delineation of the motor disorder of Lesch-Nyhan disease.

Authors:  H A Jinnah; Jasper E Visser; James C Harris; Alfonso Verdu; Laura Larovere; Irene Ceballos-Picot; Pedro Gonzalez-Alegre; Vladimir Neychev; Rosa J Torres; Olivier Dulac; Isabelle Desguerre; David J Schretlen; Kenneth L Robey; Gabor Barabas; Bastiaan R Bloem; William Nyhan; Raquel De Kremer; Gary E Eddey; Juan G Puig; Stephen G Reich
Journal:  Brain       Date:  2006-03-20       Impact factor: 13.501

8.  Tetrahydrobiopterin deficiency and dopamine loss in a genetic mouse model of Lesch-Nyhan disease.

Authors:  K Hyland; S Kasim; K Egami; L A Arnold; H A Jinnah
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 9.  Dopamine function in Lesch-Nyhan disease.

Authors:  W L Nyhan
Journal:  Environ Health Perspect       Date:  2000-06       Impact factor: 9.031

10.  CFTR activator increases intestinal fluid secretion and normalizes stool output in a mouse model of constipation.

Authors:  Onur Cil; Puay-Wah Phuan; Sujin Lee; Joseph Tan; Peter M Haggie; Marc H Levin; Liang Sun; Jay R Thiagarajah; Tonghui Ma; A S Verkman
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-01-09
View more
  1 in total

1.  Anti-inflammatory and antioxidant effects of muscarinic acetylcholine receptor (mAChR) activation in the rat hippocampus.

Authors:  Monica Frinchi; Domenico Nuzzo; Pietro Scaduto; Marta Di Carlo; Maria F Massenti; Natale Belluardo; Giuseppa Mudò
Journal:  Sci Rep       Date:  2019-10-02       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.